The proportion of Th1 cells, which prevail in gut mucosa, is decreased in inflammatory bowel syndrome
暂无分享,去创建一个
M. De Vos | G. Verbruggen | E. Veys | C. Cuvelier | P. Demetter | F. de Keyser | D. Baeten | H. Mielants | N. Damme | N. van Damme | N. Van Damme | Eric Veys | Pieter Demetter | D. Baeten | F. D. Keyser | M. Vos | Gust Verbruggen
[1] M. De Vos,et al. Flow cytometric analysis of gut mucosal lymphocytes supports an impaired Th1 cytokine profile in spondyloarthropathy , 2001, Annals of the rheumatic diseases.
[2] E. Märker-Hermann,et al. Azathioprine, Mycophenolate Mofetil, and Methotrexate Specifically Modulate Cytokine Production by T Cells , 1998, Annals of the New York Academy of Sciences.
[3] H. Makino,et al. Flow cytometric single-cell analysis of cytokine production by CD4+ T cells in synovial tissue and peripheral blood from patients with rheumatoid arthritis. , 1998, Arthritis and rheumatism.
[4] A. Abbas,et al. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. , 1998, Science.
[5] K. Nishida,et al. Expression of interleukin-12 in synovial tissue from patients with rheumatoid arthritis. , 1998, Arthritis and rheumatism.
[6] S. Targan,et al. A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease. , 1997, Journal of immunology.
[7] K. Schön,et al. Interferon‐γ receptor‐deficient mice exhibit impaired gut mucosal immune responses but intact oral tolerance , 1997, Immunology.
[8] P. Desreumaux,et al. Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease. , 1997, Gastroenterology.
[9] M. Neurath,et al. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. , 1996, Journal of immunology.
[10] M. De Vos,et al. Long-term evolution of gut inflammation in patients with spondyloarthropathy. , 1996, Gastroenterology.
[11] T. Mosmann,et al. The expanding universe of T-cell subsets: Th1, Th2 and more. , 1996, Immunology today.
[12] D. Metcalfe,et al. Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies. , 1995, Journal of immunological methods.
[13] M. De Vos,et al. The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint. , 1995, The Journal of rheumatology.
[14] G. Lack,et al. Decreased frequency of interferon-gamma- and interleukin-2-producing cells in patients with atopic diseases measured at the single cell level. , 1995, The Journal of allergy and clinical immunology.
[15] B. Volk,et al. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT‐PCR) , 1995, Clinical and experimental immunology.
[16] A. Cope,et al. Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis. , 1994, The Journal of clinical investigation.
[17] W. Paul,et al. Lymphocyte responses and cytokines , 1994, Cell.
[18] S. Anderson,et al. Regulation of CD4 and CD8 expression on mouse T cells. Active removal from the cell surface by two mechanisms. , 1993, Journal of immunology.
[19] J. Banchereau,et al. Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10 , 1993, The Journal of experimental medicine.
[20] J A Walker-Smith,et al. Interleukin-2- and interferon-gamma-secreting T cells in normal and diseased human intestinal mucosa. , 1993, Immunology.
[21] R. de Waal Malefyt,et al. Interleukin 10 inhibits allogeneic proliferative and cytotoxic T cell responses generated in primary mixed lymphocyte cultures. , 1992, International immunology.
[22] R. de Waal Malefyt,et al. IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells. , 1992, Journal of immunology.
[23] C. Dinarello,et al. Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[24] T. Bayless,et al. Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis. , 1992, Gastroenterology.
[25] J. Brynskov,et al. Increased concentrations of interleukin 1 beta, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease. , 1992, Gut.
[26] C. Fiocchi,et al. Loss of interleukin-2-producing intestinal CD4+ T cells in inflammatory bowel disease. , 1991, Gastroenterology.
[27] C G Figdor,et al. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes , 1991, The Journal of experimental medicine.
[28] T. Mosmann,et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. , 1991, Journal of immunology.
[29] J. Markowitz,et al. Immunology of inflammatory bowel disease: summary of the proceedings of the Subcommittee on Immunosuppressive Use in IBD. , 1991, Journal of pediatric gastroenterology and nutrition.
[30] W. Paul,et al. Interleukin-4 : A Prototypic Immunoregulatory Lymphokine , 2003 .
[31] M. Capobianchi,et al. Spontaneous release of interferon gamma by intestinal lamina propria lymphocytes in Crohn's disease. Kinetics of in vitro response to interferon gamma inducers. , 1991, Gut.
[32] B. Sander,et al. Assessment of Cytokines by Immunofluorescence and the Paraformaldehyde‐Saponin Procedure , 1991, Immunological reviews.
[33] A. Cooke,et al. Tumour necrosis factor‐alpha and interferon‐gamma production measured at the single cell level in normal and inflamed human intestine , 1990, Clinical and experimental immunology.
[34] P. Hart,et al. Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[35] C. Fiocchi,et al. Interferon gamma production by human intestinal mucosal mononuclear cells. Decreased levels in inflammatory bowel disease. , 1988, Digestive diseases and sciences.
[36] D. Cantrell,et al. The interleukin-2 T-cell system: a new cell growth model. , 1984, Science.
[37] J. Finke,et al. Interleukin 2 activity of human intestinal mucosa mononuclear cells. Decreased levels in inflammatory bowel disease. , 1984, Gastroenterology.
[38] R. Gallo,et al. RC Gallo lymphocytes Human T-lymphocyte growth factor : regulation of growth and function of T , 1981 .
[39] D. Jewell. The Immunology of Ulcerative Colitis and Crohn’s Disease , 1979 .